Printer Friendly

Printed from http://www.researchandmarkets.com/reports/364464

North American Fine Chemicals Market - Investment Analysis and Growth Opportunities

Description:


Focus on Niche Markets Augurs Well for Fine Chemicals Market
The fine chemicals market in North America is in a crucial phase. The restructuring efforts of the pharmaceutical fine chemicals companies, increase in the new order bookings, and greater focus on niche markets are leading to a rise in the capacity utilization rates, thus benefiting enterprises in these markets. The intense competition from the Asian companies, especially Indian and Chinese, coupled with factors such as overcapacity and limited numbers of drug approvals are proving to be hurdles for market growth. The fast growing high potent active pharmaceutical ingredients (HPAPI) and hazardous chemistry markets are emerging as viable revenue-earning alternatives to pharmaceutical intermediaries.
This Frost & Sullivan research service examines the North American fine chemicals market and segments it into pharmaceutical intermediates, active pharmaceutical ingredients, contract biopharma, and agrochemical intermediates. The study analyzes and provides financial, marketing, and business development executives with topical and in-depth information on current trends and issues that are likely to impact their investment and financial decisions.
Pharmaceutical Production Restructuring to Drive the North American Fine Chemicals Market
The production restructuring announced by pharmaceutical majors, while driving the North American fine chemicals market on the whole, could benefit the preferred suppliers the most. Importantly, in order to meet the growing requirements from the pharmaceutical companies, fine chemicals enterprises must opt for consolidation to attain a critical mass and decrease the prevalent degree of fragmentation. Pure play companies could opt for the acquisition route, as they are currently undervalued, thus providing an ideal situation for the entry of private equity participants, notes the analyst of this research service. Further, it is likely that the fine chemicals market will grow inorganically, as a result of the increased level of consolidation among participants.
Providing Quality at Competitive Prices Crucial for Facing the Asian Challenge
Fine chemicals companies - other than those catering to niche markets such as HPAPI, hazardous chemistry (HC), and contract biopharma - will find it highly challenging to survive in the North American region due to a likely increase in outsourcing to the Asian countries as the Asian units offer advantages in terms of cost, time to market, reliability, and quality.
Financially, due to the rising demand from markets such as HPAPI, both the interest coverage and net profit margin witnessed an increase in 2004, a trend that continued in 2005 due to the increased orders. To capitalize on this, participants need to focus on factors such as building close customer relationships, improving the speed of delivery, flexibility, product quality, and price to ensure a steady stream of revenue.

 
Contents:
1. Executive Summary

- 1. Executive Summary

- - 1. Executive Summary

2. Introduction

- 1. Introduction

- - 1. Introduction

- 2. Methodology

- - 1. Methodology

3. Investment Analysis and Growth Opportunities in the Fine Chemicals Industry

- 1. Industry Fundamentals

- - 1. Industry Fundamentals

- - 2. Pharmaceutical Intermediates and Active Pharmaceutical Ingredients

- - 3. Contract Biopharma

- - 4. Agrochemical Intermediates

- 2. Industry Economics

- - 1. Pharmaceutical Intermediates and Active Pharmaceutical Ingredients

- - 2. Contract Biopharma

- - 3. Agrochemical Intermediates

- 3. Value Chain Analysis-- 1. Pharmaceutical Intermediates and Active Pharmaceutical Ingredients

- - 2. Contract Biopharma

- - 3. Agrochemical Intermediates

- 4. Investment Themes

- - 1. Investment Themes

- 5. Sector Scorecard

- - 1. Sector Scorecard

- 6. Growth Monitor

- - 1. Frost & Sullivan Fine Chemicals Growth Monitor

- 7. Company Scorecard

- - 1. Company Scorecard

4. Financial Benchmarking and Valuation

- 1. Frost & Sullivan Fine Chemicals Universe

- - 1. Frost & Sullivan Fine Chemicals Universe

- 2. Financial Analysis

- - 1. Year-over-Year Sales Growth

- - 2. Research and Development to Sales

- - 3. EBIDTA Margin

- - 4. Operating Profit Margin

- - 5. Interest Coverage and Net Profit Margin

- - 6. Interest Coverage and Debt-Equity Ratio

- - 7. Capital Expenditure to Depreciation

- - 8. Return on Capital Employed

- - 9. Return on Equity

- 3. Valuations

- - 1. Historical Valuation based on Sales and Profitability

- - 2. Frost & Sullivan Stock Index Performance

- - 3. Year to Date Performance

- - 4. Private Equity and Venture Capital Activity

- - 5. Industry Growth Outlook

- - 4. Mergers and Acquisitions

- - 1. Mergers and Acquisition

List Of Figures

Chapter 3

- Fine Chemicals Market: Sector Scorecard (North America), 2005
- Fine Chemicals Market: Growth Monitor (North America), 2004
- Fine Chemicals Market: Company Scorecard (North America), 2005

Chapter 4

- Fine Chemicals Market: Frost & Sullivan Fine Chemicals Universe (North America), 2005
- Fine Chemicals Market: Sales Year-over-Year Growth (North America), 2000-2004
- Fine Chemicals Market: R&D to Sales (North America), 1998-2004
- Fine Chemicals Market: EBIDTA Margin (North America), 1998-2004
- Fine Chemicals Market: Operating Profit Margin (North America), 1998-2004
- Fine Chemicals Market: Net Profit Margin (North America), 1998-2004
- Fine Chemicals Market: Interest Coverage (North America), 1998-2004
- Fine Chemicals Market: Debt Equity Ratio (North America), 1998-2004
- Fine Chemicals Market: Capital Expenditure to Depreciation (North America), 1998-2004
- Fine Chemicals Market: Return on Capital Employed (North America), 1998-2004
- Fine Chemicals Market: Return on Equity (North America), 1998-2004
- Fine Chemicals Market: Stock Performance Highlights (North America), January 2000-September 2005
- Fine Chemicals Market: Most Active Venture Capital Firms in the U.S. Biopharmaceutical Industry (North America), June 2004-May 2005
- Fine Chemicals Market: Median Amount Invested in a Round of Financing Biopharmaceuticals and Industry in U.S. (North America), 1999 Q1-2005 Q2
- Fine Chemicals Market: Median Pre-money Valuation for U.S. (North America), 1999 Q1-2005 2Q
- Fine Chemicals Market: U.S. Venture-Backed IPO's (North America), 1998-2004
- Fine Chemicals Market: U.S. Venture-Backed IPO’s (North America), 2004 Q1-2005 Q3
- Fine Chemicals Market: Construction and Engineering Database (North America), 2005
- Fine Chemicals Market: Industry Growth Outlook (North America), 2005
- Fine Chemicals Market: Mergers and Acquisitions (North America), 2000-2005


 
Ordering:
Order Online - visit http://www.researchandmarkets.com/reports/364464

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

 
Page 1 of 2
Printed Dec 22, 2014
4:19:15 PM

Fax order form

To place a fax order simply print this form, fill in and fax the completed form to the number below. If you have any questions please email help@researchandmarkets.net

Order information

Please verify that the product information is correct and select the format you require.

Product name

North American Fine Chemicals Market - Investment Analysis and Growth Opportunities

Web Address

http://www.researchandmarkets.com/reports/364464

Office Code

SCOI7T

 

Report Formats

Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (PDF) - Site License USD 6,500
Electronic (PDF) - Enterprisewide USD 8,000
Electronic and Hard Copy (PDF) - Enterprisewide USD 8,500 + USD 63 Shipping/Handling *
Electronic and Hard Copy (PDF) - Site License USD 7,000 + USD 63 Shipping/Handling *

* Shipping/Handling is only charged once per order.

Contact information

Please enter all the information below in block capitals.

Title:
Mr Mrs Dr Miss Ms Prof
First Name:
Last Name:
Email Address:
Job Title:
Organisation:
Address:
City:
Postal / Zip Code:
Country:
Phone Number:
Fax Number:

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)

Page 2 of 2
Printed Dec 22, 2014
4:19:15 PM

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

Pay by Credit Card:

American Express

Diners Club

Master Card

Visa

Cardholder's Name:
Cardholder's Signature:
Expiry Date:
/
Card Number:
CVV Security Code:
Issue date:
/ (Diners Club only)
 
Pay by Check:

Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

 
Pay by Wire Transfer:

Please transfer funds to:

Account Number:
83313083
Sort Code:
98-53-30
Swift Code:
ULSBIE2D
IBAN Number:
IE78ULSB98533083313083
Bank Address:
Ulster Bank,
27-35 Main Street
Blackrock,
Co. Dublin
Ireland.
 

If you have a Marketing Code please enter it below:

Marketing Code:

Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)